CRCM LP 对 ARTV 的持仓历史
LATIGO BIOTHERAPEUTICS INC · 医疗保健
CRCM LP 在 Q3 2026 的 13F 申报中披露持有 ARTV(LATIGO BIOTHERAPEUTICS INC)25,386 股,市值约 US$424K,约占其申报组合的 0.24%,在其申报持仓中市值排名第 15 位。 CRCM LP 于 Q3 2026 首次申报该持仓。
最后更新: 2026-11-12 · 来源: SEC EDGAR Form 13F-HR
CRCM LP 对 ARTV 的持仓演变
CRCM LP 于 Q3 2026 首次披露 ARTV 持仓:25,386 股(约 US$424K)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2026 | 25.39K | $423.95K | 新进 |
关于 ARTV 与 13F 数据
ARTV(LATIGO BIOTHERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 66 只申报持有 ARTV,申报仓位最大的包括:RA CAPITAL MANAGEMENT, L.P. (US$174.2M), 5AM Venture Management, LLC (US$22.8M), Venrock Adviser, LLC (US$19.8M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 ARTV 的基金
- RA CAPITAL MANAGEMENT, L.P. 17.96M 股 · $174.17M · Q2 2026
- 5AM Venture Management, LLC 2.35M 股 · $22.83M · Q2 2026
- Venrock Adviser, LLC 2.04M 股 · $19.82M · Q2 2026
- Caligan Partners LP 1.74M 股 · $16.84M · Q2 2026
- Sanofi 672.78K 股 · $11.24M · Q3 2026
- Samsara BioCapital, LLC 954.86K 股 · $9.26M · Q2 2026
- Blue Owl Capital Holdings LP 874.54K 股 · $8.48M · Q2 2026
- Propel Bio Management, LLC 696.44K 股 · $6.76M · Q2 2026
- SILVERARC CAPITAL MANAGEMENT, LLC 525.00K 股 · $5.09M · Q2 2026
- ACUTA CAPITAL PARTNERS, LLC 260.42K 股 · $2.53M · Q2 2026
- Revelation Capital Management, LLC 299.31K 股 · $2.13M · Q3 2026
- KVP Capital Advisors, LP 200.00K 股 · $1.94M · Q2 2026
常见问题
How long has CRCM LP held ARTV?
CRCM LP has disclosed ARTV holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is CRCM LP's current position in ARTV?
As of Q3 2026, CRCM LP holds 25.39K shares of ARTV (LATIGO BIOTHERAPEUTICS INC), valued at $423.95K, representing 0.24% of its reported portfolio and ranking #15.
Has CRCM LP been buying or selling ARTV?
In the latest 13F filing (Q3 2026), CRCM LP newly opened its position in ARTV.
Which other funds hold ARTV?
Other major institutional holders of ARTV include RA CAPITAL MANAGEMENT, L.P., 5AM Venture Management, LLC, Venrock Adviser, LLC, among 66 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.